ARP-1536

N/A

Report date: 2025/04/09 16:02:45

Base Information

Drug NameARP-1536
Drug Alias NameARP-1536
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionReceptor-type tyrosine-protein phosphatase beta inhibitors
TargetsReceptor-type tyrosine-protein phosphatase beta
Therapy Area/IndicationsDiabetic macular oedemaKidney DiseasesMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWhitehawk Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWhitehawk Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaKidney DiseasesMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A